MyFinsight
Home
Blog
About
Contact
dare: the balance sheet
Download
Download image
Other current assets
$53,159
Prepaid expenses
$1,506,603
Other receivables
$369,157
Cash and cash
equivalents
$23,075,261
Other non-current
assets
$1,018,373
Finance lease
right-of-use asset
$2,244,073
Operating lease
right-of-use assets
$824,693
Property and equipment,
net
$1,657,255
Total current assets
$25,004,180
Total assets
$30,748,574
Total liabilities and
stockholders' equity...
$30,748,574
Total stockholders'
equity (deficit)
$2,857,903
Total liabilities
$27,890,671
Accumulated deficit
-$187,247,186
Accumulated other
comprehensive loss
-$395,966
Additional paid-in capital
$190,499,662
Lease liability
long-term, finance
$165,186
Lease liabilities
long-term, operating
$288,566
Liability related to the
sale of future...
$5,220,525
Deferred revenue,
non-current
$1,000,000
Total current
liabilities
$21,216,394
Common stock, 0.0001
par value...
$1,393
Current portion of lease
liability, finance
$1,869,570
Current portion of lease
liabilities, operating
$609,224
Current portion of
liability related to the...
$10,542
Deferred grant funding
$14,557,265
Accrued expenses
$2,324,931
Accounts payable
$1,844,862
Back
Back
Balance Sheet
source: myfinsight.com
Dare Bioscience, Inc. (DARE)
Dare Bioscience, Inc. (DARE)